Real-World surgery study aims to improve fistula care
NCT ID NCT04940611
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tracked 646 people with complex fistulas (abnormal tunnels) caused by Crohn's disease or other conditions. Researchers observed the standard surgical treatments patients received at their clinics and recorded outcomes like fistula closure and complications. The goal is to gather real-world evidence on what works best in everyday practice.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors understand which surgical approaches work best for complex fistulas, potentially improving future treatment guidelines.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove which surgery is best. Results may vary across clinics and patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
646 people
The number who actually took part.
- Started
-
Aug 2021
- Finished
-
Apr 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants undergoing surgical interventions to treat fistulas (CPF-CD, CD-RVF and CCF) from surgical and GI specialty sites.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Participants with CPF-CD 1. CPF-CD that meets one or more of the following criteria: * High inter-sphincteric, high trans-sphincteric, extra-sphincteric or supra-sphincteric fistula, or * Presence of greater than or equal to (\>=) 2 external openings, or * Associated perianal abscess(es) 2. Physician has made the decision to treat with a specific surgical intervention. Procedures may include: * Fistulotomy, fistula plug, fibrin glue, advancement flap (AF), ligation of inter-sphincteric fistula tract (LIFT), flap repair, fistulectomy, proctectomy, stem cell therapy, other; and seton for palliative purposes. Participants with CD-RVF: Rectovaginal fistula per physician diagnosis 1\. Physician has made the decision to treat with a specific surgical intervention. Procedures may include: * Fistulotomy, fistula plug, fibrin glue, AF, LIFT, flap repair, fistulectomy, proctectomy, stem cell therapy, gracilis muscle interposition/tissue grafts, martius procedure, abdominal procedures, other; and seton use for palliative purposes. Participants with CCF: 1. Complex cryptoglandular fistula that meets one or more of the following criteria: * Mid or high trans-sphincteric, or * Anterior in women, or * Horseshoe fistula 2. Physician has made the decision to treat with a specific surgical intervention. Procedures may include: * Fistulotomy, fistula plug, fibrin glue, AF, LIFT, flap repair, fistulectomy, proctectomy, stem cell therapy, other; and seton use for palliative purposes Exclusion Criteria: Participants who meet any below mentioned criterion among CPF-CD, CD-RVF, and CCF diagnosis will be excluded from the study. 1. Current participation in interventional clinical trials. 2. Has CPF-CD: fistula connection to bladder or another organ 3. Has CCF: diagnosis of Inflammatory Bowel Disease (IBD), including Ulcerative Colitis, and Crohn's Disease (CD).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Complex cryptoglandular fistula are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AKH - Medizinische Universitat Wien
Vienna, 1090, Austria
-
AZ Delta
Roeselare, 8800, Belgium
-
Amsterdam UMC, Locatie AMC
Amsterdam, 1105 AZ, Netherlands
-
Baptist MD Anderson Cancer Center
Jacksonville, Florida, 32207, United States
-
Baylor Research Institute
Dallas, Texas, 75204, United States
-
Broomfield Hospital
Chelmsford, Essex, CM1 7ET, United Kingdom
-
CHRU Hopital Claude Huriez
Lille, Nord, 59037, France
-
CHU de Rennes - Hopital Pontchaillou
Rennes, Ille Et Vilaine, 35000, France
-
CHU de Rouen - Hopital Charles Nicolle
Rouen, Seine Maritime, 76031, France
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Clinique CHC MontLegia
Liège, 4000, Belgium
-
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
-
Colon & Rectal Clinic
Houston, Texas, 77030, United States
-
Fakultni nemocnice Brno
Brno, 625 00, Czechia
-
Fakultni nemocnice Olomouc
Olomouc, 779 00, Czechia
-
Fakultni nemocnice u sv. Anny v Brne
Brno, 656 91, Czechia
-
Fondation Maison Sante Bagatelle
Talence, Gironde, 33400, France
-
GI Alliance - Baton Rouge
Baton Rouge, Louisiana, 70809, United States
-
Groupe Hospitalier Diaconesses - Hopital De La Croix Saint Simon
Paris, 75012, France
-
Hopital Saint Joseph - Paris
Paris, 75014, France
-
Hospices Civils de Lyon (HCL) - Centre Hospitalier Lyon-Sud
Pierre-Bénite, Bouches-du-Rhone, 69310, France
-
Istituto Clinico Humanitas
Rozzano, Milano, 20089, Italy
-
Jessa Ziekenhuis Hospital
Hasselt, 3500, Belgium
-
Lenox Hill Hospital PRIME
New York, New York, 10075, United States
-
NH Hospital a.s.Nemocnice Horovice
Hořovice, 268 31, Czechia
-
Nottingham University Hospital
Nottingham, Nottinghamshire, NG7 2UH, United Kingdom
-
Penn Medicine PA
Philadelphia, Pennsylvania, 19104, United States
-
Premier Health
Dayton, Ohio, 45409, United States
-
Rambam Health Care Center
Haifa, 3109601, Israel
-
Royal Victoria Infirmary.
Newcastle upon Tyne, Tyne & Wear, NE1 4LP, United Kingdom
-
Shamir Medical Center (Assaf Harofeh)
Be’er Ya‘aqov, 7033001, Israel
-
St. Pauls Hospital
Vancouver, British Columbia, V6Z 1Y6, Canada
-
Tel Aviv Sourasky Medical Center
Tel Aviv, 64239, Israel
-
Temple University Hospital
Philadelphia, Pennsylvania, 19140, United States
-
UMC Utrecht
Utrecht, 3508 GA, Netherlands
-
UNC Hospitals
Chapel Hill, North Carolina, 27599, United States
-
UZ Antwerpen
Antwerp, 2650, Belgium
-
University of Kansas Medical Center Research Institute, Inc.
Kansas City, Kansas, 66160, United States
-
University of South Florida - PARENT
Tampa, Florida, 33612, United States
-
Vanderbilt University Medical Center- GI Endoscopy Lab
Nashville, Tennessee, 37212, United States
-
Wolfson Medical Center
Holon, 58100, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple hospital checklist could flag hidden malnutrition in kids with IBD
- Fat cell therapy shows promise for Hard-to-Heal gut holes
- Massive study sheds light on rare brain vessel condition
- Stem cell shot for Crohn's pouch fistulas shows early promise but study halted
- New stent aims to seal Post-Surgery leaks without another operation
- Stem cell shot for Crohn's fistulas: hope or hype?